4.7 Article

Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer

Journal

INTERNATIONAL JOURNAL OF CANCER
Volume 140, Issue 6, Pages 1425-1435

Publisher

WILEY
DOI: 10.1002/ijc.30557

Keywords

iTRAQ; heat shock protein 47; lymph node metastasis; colorectal cancer

Categories

Funding

  1. Ministry of Education, Culture, Sports, Science and Technology, Japan [25462018]
  2. Grants-in-Aid for Scientific Research [25462018, 16K10533] Funding Source: KAKEN

Ask authors/readers for more resources

The discovery of biomarkers to predict the potential for lymph node (LN) metastasis in patients with colorectal cancer (CRC) is essential for developing improved strategies for treating CRC. In the present study, they used isobaric tags for relative and absolute quantitation to conduct a proteomic analysis designed to identify novel biomarkers for predicting LN metastasis in patients with CRC. They identified 60 differentially expressed proteins specifically associated with LN metastasis in CRC patients and classified the molecular and functional characteristics of these proteins by bioinformatic approaches. A literature search led them to select heat shock protein 47 (HSP47) as the most suitable candidate biomarker for predicting LN metastasis. Validation analysis by immunohistochemistry showed that HSP47 expression in patients with CRC and the number of HSP47-positive spindle cells in the tumor stroma were significantly higher compared with those in adjacent normal colonic mucosa, and the number of the latter cells increased with tumor progression. Further, the number of HSP47-positive spindle cells in stroma was a more informative marker for identifying LN metastasis than HSP47expression. Multivariate analysis identified spindle cells that expressed elevated levels of HSP47 as an independent predictive biomarker for CRC with LN metastasis. Moreover, these cells served as an independent marker of disease-free and overall survival of patients with CRC. Their data indicate that the number of HSP47-positive spindle cells in the stroma of CRC may serve as a novel predictive biomarker of LN metastasis, early recurrence and poor prognosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Oncology

Non-coding RNAs as liquid biopsy biomarkers in cancer

Shusuke Toden, Ajay Goel

Summary: Non-coding RNAs, previously considered as non-functional, have been found to play a critical role in various cancers and have potential as clinical biomarkers. Among them, microRNAs are extensively studied as liquid biopsy biomarkers. High-throughput sequencing technology allows comprehensive characterization of non-coding RNA expression profiles in different cancers. Technological advancements have also made it possible to identify previously unrecognized biomarkers in cancer patients.

BRITISH JOURNAL OF CANCER (2022)

Article Oncology

A blood-based noninvasive miRNA signature for predicting survival outcomes in patients with intrahepatic cholangiocarcinoma

Yuma Wada, Mitsuo Shimada, Yuji Morine, Tetsuya Ikemoto, Yu Saito, Hideo Baba, Masaki Mori, Ajay Goel

Summary: This study identified a 7-miRNA panel that could accurately predict survival outcomes in patients with ICC. The risk-stratification model showed superior performance compared to other models, demonstrating its accuracy in predicting prognosis for ICC patients.

BRITISH JOURNAL OF CANCER (2022)

Article Oncology

Genome-wide methylation profiling identifies a novel gene signature for patients with synchronous colorectal cancer

Yasuyuki Okada, Fuduan Peng, Jose Perea, Luis Corchete, Luis Bujanda, Wei Li, Ajay Goel

Summary: A novel methylation signature risk-scoring model was developed to reliably identify patients with synchronous colorectal cancer (SyCRC), which has the potential to improve the diagnosis and management of colorectal cancer (CRC) patients.

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

A liquid biopsy signature for predicting early recurrence in patients with gastric cancer

Keisuke Okuno, Shuichi Watanabe, Souvick Roy, Mitsuro Kanda, Masanori Tokunaga, Yasuhiro Kodera, Yusuke Kinugasa, Ajay Goel

Summary: We established a miRNA-based liquid biopsy signature that can reliably predict early recurrence in gastric cancer patients by analyzing miRNA expression profiling. Additionally, a model combining the miRNA signature, microsatellite instability (MSI) status, and tumor size exhibited better predictive performance and was successfully validated in another independent cohort. Finally, we translated the miRNA signature into a liquid biopsy assay and demonstrated its independence as a predictor for early recurrence.

BRITISH JOURNAL OF CANCER (2023)

Letter Gastroenterology & Hepatology

Diagnostic Specificity of Blood-based MicroRNA Signatures Should Be Fully Evaluated Reply

Kota Nakamura, Ajay Goel

GASTROENTEROLOGY (2023)

Article Genetics & Heredity

Transcriptomic Profiling Reveals an Enhancer RNA Signature for Recurrence Prediction in Colorectal Cancer

Divya Sahu, Chen-Ching Lin, Ajay Goel

Summary: This study identified eRNA panels that can predict tumor recurrence in patients with colorectal cancer. These panels outperformed TNM staging in predicting recurrence and showed excellent accuracy. The findings of this study have the potential to improve risk stratification and guide precision oncology treatments for colorectal cancer patients.

GENES (2023)

Article Biochemistry & Molecular Biology

Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma

Keisuke Okuno, Caiming Xu, Silvia Pascual-Sabater, Masanori Tokunaga, Tetsuji Takayama, Haiyong Han, Cristina Fillat, Yusuke Kinugasa, Ajay Goel

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer due to its resistance to chemotherapy, including Gemcitabine (Gem). This study aimed to investigate whether the natural botanical Andrographis (Andro) can reverse Gem resistance in PDAC cells. The findings suggest that Andro can enhance the anti-cancer potential of Gem by regulating the ERBB3 and calcium signaling pathways.

BIOMEDICINES (2023)

Article Oncology

Ginseng mediates its anticancer activity by inhibiting the expression of DNMTs and reactivating methylation-silenced genes in colorectal cancer

Keisuke Okuno, Muhammad Yogi Pratama, Jiang Li, Masanori Tokunaga, Xin Wang, Yusuke Kinugasa, Ajay Goel

Summary: This cell culture-based study demonstrated that Ginseng has the potential to fight against colorectal cancer by regulating cellular apoptosis and reversing the methylation status of silenced genes.

CARCINOGENESIS (2023)

Editorial Material Gastroenterology & Hepatology

Intratumoral Malassezia globosa Levels Predict Survival and Therapeutic Response to Adjuvant Chemotherapy in Patients With Pancreatic Ductal Adenocarcinoma

Keisuke Okuno, Masanori Tokunaga, Daniel Von Hoff, Yusuke Kinugasa, Ajay Goel

GASTROENTEROLOGY (2023)

Article Genetics & Heredity

Molecular and Sociodemographic Colorectal Cancer Disparities in Latinos Living in Puerto Rico

Julyann Perez-Mayoral, Maria Gonzalez-Pons, Hilmaris Centeno-Girona, Ingrid M. Montes-Rodriguez, Marievelisse Soto-Salgado, Belisa Suarez, Natalia Rodriguez, Giancarlo Colon, Javier Sevilla, Daphne Jorge, Xavier Llor, Rosa M. Xicola, Doris H. Toro, Luis Tous-Lopez, Marla Torres-Torres, Jose S. Reyes, Nicolas Lopez-Acevedo, Ajay Goel, Segundo Rodriguez-Quilichini, Marcia Cruz-Correa

Summary: This study analyzed the molecular markers and clinicopathologic features of colorectal tumors from Puerto Rico to better understand the molecular pathways leading to colorectal cancer in this Hispanic subpopulation. The results showed distinct differences in the prevalence of molecular markers among tumors from Puerto Rico compared to other racial/ethnic groups, suggesting a unique molecular carcinogenic pathway among Hispanics.

GENES (2023)

Article Cell Biology

Curcumin-Mediated Resistance to Lenvatinib via EGFR Signaling Pathway in Hepatocellular Carcinoma

Katsuki Miyazaki, Yuji Morine, Caiming Xu, Chiharu Nakasu, Yuma Wada, Hiroki Teraoku, Shinichiro Yamada, Yu Saito, Tetsuya Ikemoto, Mitsuo Shimada, Ajay Goel

Summary: This study demonstrates that the combination of Curcumin and Lenvatinib exhibits synergistic anti-tumor efficacy in Lenvatinib-resistant HCC cell lines. Curcumin reverses Lenvatinib resistance through inhibition of the EGFR pathway. These findings suggest that the combination therapy has potential clinical application for adjunctive treatment in HCC.

CELLS (2023)

Article Chemistry, Medicinal

Curcumin and Andrographis Exhibit Anti-Tumor Effects in Colorectal Cancer via Activation of Ferroptosis and Dual Suppression of Glutathione Peroxidase-4 and Ferroptosis Suppressor Protein-1

Katsuki Miyazaki, Caiming Xu, Mitsuo Shimada, Ajay Goel

Summary: Colorectal cancer (CRC) is a major cause of cancer-related deaths worldwide. Limitations of current CRC chemotherapeutic drugs include toxicity, side effects, and high costs. In this study, a combination of curcumin and andrographis showed superior anti-tumor effects in CRC cells by inhibiting cell proliferation, invasion, colony formation, and inducing apoptosis. The combination treatment also activated the ferroptosis pathway and downregulated the expression of GPX-4 and FSP-1, leading to accumulation of reactive oxygen species and lipid peroxides in CRC cells.

PHARMACEUTICALS (2023)

Editorial Material Biochemistry & Molecular Biology

The Non-Coding RNA Journal Club: Highlights on Recent Papers-12

Patrick K. T. Shiu, Mirolyuba Ilieva, Anja Holm, Shizuka Uchida, Johanna K. DiStefano, Agnieszka Bronisz, Ling Yang, Yoh Asahi, Ajay Goel, Liuqing Yang, Ashok Nuthanakanti, Alexander Serganov, Suresh K. Alahari, Chunru Lin, Barbara Pardini, Alessio Naccarati, Jing Jin, Beshoy Armanios, Xiao-bo Zhong, Nikolaos Sideris, Salih Bayraktar, Leandro Castellano, Andre P. Gerber, He Lin, Simon J. Conn, Doha Magdy Mostafa Sleem, Lisa Timmons

NON-CODING RNA (2023)

Article Oncology

Genetic Variants as Predictors of the Success of Colorectal Cancer Treatments

Koldo Garcia-Etxebarria, Ane Etxart, Maialen Barrero, Beatriz Nafria, Nerea Miren Segues Merino, Irati Romero-Garmendia, Ajay Goel, Andre Franke, Mauro D'Amato, Luis Bujanda

Summary: This study found that some genetic polymorphisms (SNPs), when combined with clinical data, can be used as predictors for colorectal cancer (CRC) outcomes. Additionally, new SNPs associated with CRC outcomes were detected and may serve as feasible markers.

CANCERS (2023)

Article Oncology

Anal cancer screening results from 18-to-34-year-old men who have sex with men living with HIV

Yuxin Liu, Swati Bhardwaj, Keith Sigel, John Winters, Joseph Terlizzi, Michael M. Gaisa

Summary: This study investigated the prevalence and severity of anal HPV disease among MSM LWH under the age of 35, finding a high prevalence of HPV infection and precancer but no cases of invasive anal cancer. This supports the adoption of age-based anal cancer screening for this population.

INTERNATIONAL JOURNAL OF CANCER (2024)